Literature DB >> 26569087

Recognition and management of arrhythmias in adult congenital heart disease.

Christopher J McLeod1, Carole Warnes.   

Abstract

PURPOSE OF REVIEW: Adults with congenital heart disease now outnumber children with these syndromes in developed countries. This has seen a surge in the care required for these patients, and the development of an entirely new realm of cardiology. Arrhythmia is one of the most common causes of morbidity and mortality in this group, and this review highlights current approaches to recognition and management. RECENT
FINDINGS: Atrial arrhythmias are especially common in this group of patients, while pacemaker or implantable cardioverter defibrillator implantation and cardiac ablation are also frequently necessary. The presentation and management of these entities present salient differences for the clinician--for both acute and chronic care--and more recently a national societal consensus statement has attempted to encapsulate the best approach. Without any level of evidence A, all recommendations are based on data derived from nonrandomized studies or only expert/consensus opinion. This review is aimed at providing current opinion on optimum clinical care in this arena in lieu of this publication and the more novel corroborative clinical studies.
SUMMARY: Recognition and appropriate management of arrhythmia in adults with congenital heart disease frequently differ from those patients with a normal heart or acquired heart disease. Early diagnosis and proper treatment are essential in this complex patient category.

Entities:  

Mesh:

Year:  2016        PMID: 26569087     DOI: 10.1097/HCO.0000000000000251

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  4 in total

1.  A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle.

Authors:  Cai-Xia Lu; Wei Wang; Qian Wang; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

2.  TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus.

Authors:  Ri-Tai Huang; Juan Wang; Song Xue; Xing-Biao Qiu; Hong-Yu Shi; Ruo-Gu Li; Xin-Kai Qu; Xiao-Xiao Yang; Hua Liu; Ning Li; Yan-Jie Li; Ying-Jia Xu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2017-03-11       Impact factor: 3.738

3.  The efficacy of bosentan combined with vardenafil in the treatment of postoperative pulmonary hypertension in children with congenital heart disease: A protocol of randomized controlled trial.

Authors:  Chao Gao; Junting Liu; Runhan Zhang; Manting Zhao; Yongli Wu
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

4.  MEF2C loss-of-function mutation contributes to congenital heart defects.

Authors:  Xiao-Hui Qiao; Fei Wang; Xian-Ling Zhang; Ri-Tai Huang; Song Xue; Juan Wang; Xing-Biao Qiu; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2017-09-08       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.